Genetic rearrangements and TRKA activation have been observed in several malignancies, including colon cancer and papillary thyroid carcinoma, resulting in the constitutive activation of TRKA signaling [11]. This evidence concerns the gene NTRK1 and differentiated thyroid carcinoma.